Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rakhi Kilaru

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Pancreas|April 19, 2011
Intravenous synthetic secretin reduces the incidence of pancreatitis induced by endoscopic retrograde cholangiopancreatographyPaul S Jowell, Malcolm S Branch, Seymour H Fein, et al.
European Heart Journal|February 3, 2007
Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: results from four large clinical trialsKenneth W Mahaffey, Matthew T Roe, Rakhi Kilaru, et al.
American Heart Journal|August 1, 2006
Racial differences are seen in blood pressure response to fosinopril in hypertensive childrenSharad Menon, Katherine Y Berezny, Rakhi Kilaru, et al.
Therapeutic Innovation & Regulatory Science|December 26, 2023
An Overview of Current Statistical Methods for Implementing Quality Tolerance LimitsRakhi Kilaru, Sonia Amodio, Yasha Li, et al.
Circulation|January 24, 2002
Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trialMarino Labinaz, Rakhi Kilaru, Karen Pieper, et al.
Therapeutic Innovation & Regulatory Science|January 20, 2024
Correction: An Overview of Current Statistical Methods for Implementing Quality Tolerance LimitsRakhi Kilaru, Sonia Amodio, Yasha Li, et al.
American Heart Journal|July 2, 2005
Incidence, predictors, and outcomes of high-degree atrioventricular block complicating acute myocardial infarction treated with thrombolytic therapyTrip J Meine, Sana M Al-Khatib, John H Alexander, et al.
The American Journal of Cardiology|November 26, 2008
Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry)Jonathan P Piccini, Patrick M Hranitzky, Rakhi Kilaru, et al.
European Heart Journal|June 24, 2005
Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registryKarolina E Szummer, Scott D Solomon, Eric J Velazquez, et al.
Archives of Internal Medicine|October 12, 2005
Left ventricular assessment in myocardial infarction: the VALIANT registryAdrian F Hernandez, Eric J Velazquez, Scott D Solomon, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Pancreas|April 19, 2011
Intravenous synthetic secretin reduces the incidence of pancreatitis induced by endoscopic retrograde cholangiopancreatographyPaul S Jowell, Malcolm S Branch, Seymour H Fein, et al.
European Heart Journal|February 3, 2007
Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: results from four large clinical trialsKenneth W Mahaffey, Matthew T Roe, Rakhi Kilaru, et al.
American Heart Journal|August 1, 2006
Racial differences are seen in blood pressure response to fosinopril in hypertensive childrenSharad Menon, Katherine Y Berezny, Rakhi Kilaru, et al.
Therapeutic Innovation & Regulatory Science|December 26, 2023
An Overview of Current Statistical Methods for Implementing Quality Tolerance LimitsRakhi Kilaru, Sonia Amodio, Yasha Li, et al.
Circulation|January 24, 2002
Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trialMarino Labinaz, Rakhi Kilaru, Karen Pieper, et al.
Therapeutic Innovation & Regulatory Science|January 20, 2024
Correction: An Overview of Current Statistical Methods for Implementing Quality Tolerance LimitsRakhi Kilaru, Sonia Amodio, Yasha Li, et al.
American Heart Journal|July 2, 2005
Incidence, predictors, and outcomes of high-degree atrioventricular block complicating acute myocardial infarction treated with thrombolytic therapyTrip J Meine, Sana M Al-Khatib, John H Alexander, et al.
The American Journal of Cardiology|November 26, 2008
Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry)Jonathan P Piccini, Patrick M Hranitzky, Rakhi Kilaru, et al.
European Heart Journal|June 24, 2005
Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registryKarolina E Szummer, Scott D Solomon, Eric J Velazquez, et al.
Archives of Internal Medicine|October 12, 2005
Left ventricular assessment in myocardial infarction: the VALIANT registryAdrian F Hernandez, Eric J Velazquez, Scott D Solomon, et al.
Pageof 2